- Authors:
-
Vergari, A; Cortegiani, A; Rispoli, M; Coluzzi, F; Deni, F; Leykin, Y; Luca Lorini, F; Martorano, P P; Paolicchi, A; Polati, E; Scardino, M; Corcione, A; Giarratano, A; Rossi, M
- Title:
-
Sufentanil Sublingual Tablet System: from rationale of use to clinical practice
- Year:
-
2020
- Type of item:
-
Articolo in Rivista
- Tipologia ANVUR:
- Articolo su rivista
- Language:
-
Inglese
- Referee:
-
No
- Name of journal:
- European Review of Medical and Pharmacological Science
- ISSN of journal:
- 1128-3602
- N° Volume:
-
24
- Number or Folder:
-
22
- Page numbers:
-
11891-11899
- Keyword:
-
SSTS; Neuropathic pain; Surgery; Clinical practice
- Short description of contents:
- The control of post-operative pain in Italy and other western countries is still suboptimal. In recent years, the Sufentanil Sublingual Tablet System (SSTS; Zalviso; Acel-Rx Pharmaceuticals, Redwood City, CA, USA), which is designed for patient-controlled analgesia (PCA), has entered clinical practice. SSTS enables patients to manage moderate-to-severe acute pain during the first 72 postoperative hours directly in the hospital setting. However, the role of SSTS within the current framework of options for the management of post-operative pain needs to be better established. This paper presents the position on the use of SSTS of a multidisciplinary group of Italian Experts and provides protocols for the use of this device.
- Product ID:
-
119558
- Handle IRIS:
-
11562/1037187
- Last Modified:
-
November 13, 2022
- Bibliographic citation:
-
Vergari, A; Cortegiani, A; Rispoli, M; Coluzzi, F; Deni, F; Leykin, Y; Luca Lorini, F; Martorano, P P; Paolicchi, A; Polati, E; Scardino, M; Corcione, A; Giarratano, A; Rossi, M,
Sufentanil Sublingual Tablet System: from rationale of use to clinical practice
«European Review of Medical and Pharmacological Science»
, vol.
24
, n.
22
,
2020
,
pp. 11891-11899
Consulta la scheda completa presente nel
repository istituzionale della Ricerca di Ateneo